Patient Guide: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 25 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05091424
Status: 🟢 Enrolling Now
Condition: Chronic Lymphocytic Leukemia
Phase: PHASE1

Where You Can Participate

This study is available at 25 locations across the country.

Top locations include:
  • • Rochester, Minnesota
  • • New York, New York
  • • Columbus, Ohio
  • • And 22 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia - Join Clinical Trial NCTNCT05091424

How to Join This Clinical Trial - NCTNCT05091424

Learn how to participate in this PHASE1 trial studying an investigational therapy for Chronic Lymphocytic Leukemia. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Chronic Lymphocytic Leukemia. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Chronic Lymphocytic Leukemia
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05091424 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 25 locations. Find a study site near you:

Clinical Research Site

Rochester, Minnesota 55902 - United States

Status: RECRUITING

Clinical Research Site

New York, New York 10065 - United States

Status: WITHDRAWN

Clinical Research Site

Columbus, Ohio 43210 - United States

Status: RECRUITING

Clinical Research Site

Houston, Texas 77030 - United States

Status: WITHDRAWN

Clinical Research Site

Salt Lake City, Utah 84112 - United States

Status: RECRUITING

Clinical Research Site

Woolloongabba, Queensland 4102 - Australia

Status: RECRUITING

Clinical Research Site

East Melbourne, Victoria 3002 - Australia

Status: COMPLETED

Clinical Research Site

Melbourne, Victoria 3168 - Australia

Status: RECRUITING

Clinical Research Site

Tianjin, 301600 - China

Status: RECRUITING

Clinical Research Site

Clermont-Ferrand, 63003 - France

Status: WITHDRAWN

And 15 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Chronic Lymphocytic Leukemia:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships